• LAST PRICE
    0.6001
  • TODAY'S CHANGE (%)
    Trending Up0.0051 (0.8573%)
  • Bid / Lots
    0.6000/ 1
  • Ask / Lots
    0.6200/ 58
  • Open / Previous Close
    0.6300 / 0.5950
  • Day Range
    Low 0.5500
    High 0.6300
  • 52 Week Range
    Low 0.5500
    High 2.8200
  • Volume
    214,977
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 0.595
TimeVolumeSYBX
09:32 ET49400.609901
09:44 ET1200.612486
10:04 ET49210.5837
10:44 ET10000.6128
11:12 ET13000.6059
11:39 ET1000.601
12:33 ET3000.595
12:37 ET1000.5811
12:39 ET2000.5811
01:08 ET50000.58101
01:09 ET84590.58
01:13 ET2000.575399
01:15 ET12310.5754
01:20 ET1000.57
01:26 ET311250.57
01:27 ET49680.57
01:29 ET2000.57
01:33 ET20000.57
01:38 ET20000.57
01:44 ET769000.55
01:51 ET10000.56505
01:56 ET28890.58
01:58 ET11010.57
02:05 ET10000.59168
02:14 ET20000.5898
02:16 ET20000.5885
02:25 ET10000.56
02:30 ET5000.589502
02:43 ET90000.5897
03:12 ET4000.5896
03:21 ET25000.560101
03:24 ET6000.57475
03:26 ET2000.57475
03:35 ET58870.5718
03:37 ET7000.582
03:42 ET10000.6099
03:44 ET3000.6093
03:50 ET1000.58995
03:55 ET110000.61
03:57 ET6000.600101
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSYBX
Synlogic Inc
42.0M
-0.7x
---
United StatesPTN
Palatin Technologies Inc
39.9M
-1.0x
---
United StatesDYAI
Dyadic International Inc
41.1M
-3.6x
---
United StatesALBT
Avalon Globocare Corp
39.5M
-3.2x
---
United StatesLUMO
Lumos Pharma Inc
42.0M
-1.5x
---
United StatesCRVS
Corvus Pharmaceuticals Inc
41.9M
-1.0x
---
As of 2022-11-30

Company Information

Synlogic, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of synthetic biology therapeutics for the treatment of rare, infectious, and other diseases. Its pipeline includes its lead program in phenylketonuria (PKU). The Company's PKU program includes two development candidates, SYNB1618 and SYNB1934. SYNB1618 and SYNB1934 are orally administered, non-systemically absorbed drug candidates for PKU, which is a genetic disease caused by neurotoxic levels of the amino acid Phe. Its product pipeline includes SYNB1353 and SYNB8802. SYNB1353 is an orally administered, non-systemically absorbed live biotherapeutic drug candidate engineered to consume methionine in the gastrointestinal tract (GI) total homocysteine (tHcy) in homocystinuria (HCU) patients and allowing natural protein intake. SYNB8802 is a non-systemically absorbed drug candidate developed for the treatment of enteric hyperoxaluria.

Contact Information

Headquarters
301 Binney St Ste 402CAMBRIDGE, MA, United States 02142-1030
Phone
617-401-9975
Fax
302-636-5454

Executives

Independent Chairman of the Board
Peter Barrett
President, Chief Executive Officer, Director
Aoife Brennan
Chief Financial Officer
Michael Jensen
Chief Operating Officer, Head of Technical Operation
Antoine Awad
General Counsel, Company Secretary
Brendan St. Amant

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$42.0M
Revenue (TTM)
$1.7M
Shares Outstanding
70.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.14
EPS
$-0.90
Book Value
$2.11
P/E Ratio
-0.7x
Price/Sales (TTM)
25.2
Price/Cash Flow (TTM)
---
Operating Margin
-3,917.23%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.